These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 36282144)
1. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma. Liu J; Zheng Z; Zhong J J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144 [TBL] [Abstract][Full Text] [Related]
2. Chronic allergic asthma alters m6A epitranscriptomic tagging of mRNAs and lncRNAs in the lung. Ni X; Li X; Hu B; Wang L Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36250525 [TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098 [TBL] [Abstract][Full Text] [Related]
4. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
5. Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma. Zhang J; Bai S; Yan Y; Kang H; Li G; Feng Z; Ma W; Wang X; Ren J BMC Pulm Med; 2023 Aug; 23(1):284. PubMed ID: 37537521 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer. Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272 [TBL] [Abstract][Full Text] [Related]
7. Alteration of N6-methyladenosine modification profiles in the neutrophilic RNAs following ischemic stroke. Fan J; Zhong L; Yan F; Li X; Li L; Zhao H; Han Z; Wang R; Tao Z; Zheng Y; Ma Q; Luo Y Neuroscience; 2024 Aug; 553():56-73. PubMed ID: 38945353 [TBL] [Abstract][Full Text] [Related]
8. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma. Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic, progressive and prognostic performance of m Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949 [No Abstract] [Full Text] [Related]
10. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome. Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909 [TBL] [Abstract][Full Text] [Related]
11. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis. Gao C; Kong N; Zhang F; Zhou L; Xu M; Wu L BMC Bioinformatics; 2022 Aug; 23(1):327. PubMed ID: 35941550 [TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548 [TBL] [Abstract][Full Text] [Related]
14. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma. Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357 [TBL] [Abstract][Full Text] [Related]
15. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis. Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of m6A modification patterns and m6A-related lncRNAs as potential biomarkers in lung adenocarcinoma. Wang S; Gu X; Xu D; Liu B; Qin K; Yuan X Environ Toxicol; 2024 Apr; 39(4):2285-2303. PubMed ID: 38148718 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer. Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168 [TBL] [Abstract][Full Text] [Related]
18. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma. Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma. Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747 [TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma. Sun J; Ping Y; Huang J; Zeng B; Ji P; Li D Front Cell Dev Biol; 2021; 9():705962. PubMed ID: 34422827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]